secwatch.observer — SEC 8-K summary
======================================

Issuer:     USANA HEALTH SCIENCES INC (USNA)
CIK:        0000896264
Form:       8-K
Filed at:   2023-02-07T23:59:59+00:00
Accession:  0001157523-23-000197
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

USANA Q4 net sales $228M (-15% YoY), EPS $0.66 (-36%); FY2023 guidance reiterated
--------------------------------------------------------------------------------

- Q4 net sales $228M, down 15% YoY; diluted EPS $0.66, down 36% YoY.
- FY2022 net sales $999M (-16% YoY), EPS $3.59 (-37%); operating cash flow $104M.
- Active customers 490,000, down 13% YoY but up 3% sequentially; key markets stabilized.
- FY2023 outlook: net sales $850M-$950M, diluted EPS $2.35-$3.30; wide range on China uncertainty.
- Ended with $288M cash, debt-free; $83M share buyback remaining; no Q4 repurchases.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896264/000115752323000197/0001157523-23-000197-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896264/000115752323000197/a53305227.htm
  HTML page:      https://secwatch.observer/filing/0001157523-23-000197

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer